AngioDynamics, Inc. (NASDAQ:ANGO) Shares Purchased by Manatuck Hill Partners LLC

Manatuck Hill Partners LLC lifted its stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 166.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 199,500 shares of the medical instruments supplier's stock after buying an additional 124,500 shares during the period. Manatuck Hill Partners LLC owned approximately 0.49% of AngioDynamics worth $1,827,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. SBI Securities Co. Ltd. acquired a new stake in shares of AngioDynamics during the fourth quarter worth about $28,000. R Squared Ltd purchased a new position in AngioDynamics during the 4th quarter worth approximately $49,000. US Bancorp DE grew its stake in AngioDynamics by 1,938.0% during the 4th quarter. US Bancorp DE now owns 6,705 shares of the medical instruments supplier's stock worth $61,000 after buying an additional 6,376 shares during the last quarter. Quinn Opportunity Partners LLC purchased a new stake in AngioDynamics in the fourth quarter valued at approximately $92,000. Finally, OneDigital Investment Advisors LLC boosted its holdings in shares of AngioDynamics by 14.0% in the fourth quarter. OneDigital Investment Advisors LLC now owns 12,137 shares of the medical instruments supplier's stock valued at $111,000 after acquiring an additional 1,490 shares during the period. 89.43% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reaffirmed a "buy" rating and issued a $16.00 target price (up from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

AngioDynamics Trading Up 1.1 %

Shares of ANGO traded up $0.10 during mid-day trading on Friday, hitting $9.29. 261,568 shares of the company's stock were exchanged, compared to its average volume of 557,510. AngioDynamics, Inc. has a fifty-two week low of $5.47 and a fifty-two week high of $13.50. The business's 50 day moving average is $9.47 and its two-hundred day moving average is $9.24. The firm has a market capitalization of $377.24 million, a P/E ratio of -1.65 and a beta of 0.52.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last posted its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.16. AngioDynamics had a negative return on equity of 7.26% and a negative net margin of 79.38%. The company had revenue of $72.00 million during the quarter, compared to analysts' expectations of $70.30 million. The firm's revenue was down 4.3% compared to the same quarter last year. On average, equities research analysts forecast that AngioDynamics, Inc. will post -0.37 earnings per share for the current year.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.